These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15855796)

  • 1. Interferon therapy in hemodialysis patients with chronic hepatitis C: study of tolerance, efficacy and post-transplantation course.
    Mahmoud IM; Sobh MA; El-Habashi AF; Sally ST; El-Baz M; El-Sawy E; Ghoneim MA
    Nephron Clin Pract; 2005; 100(4):c133-9. PubMed ID: 15855796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
    Campistol JM; Esforzado N; Martínez J; Roselló L; Veciana L; Modol J; Casellas J; Pons M; de Las Cuevas X; Piera J; Oliva JA; Costa J; Barrera JM; Bruguera M
    Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation.
    Casanovas-Taltavull T; Baliellas C; Benasco C; Serrano TT; Casanova A; Pérez JL; Guerrero L; González MT; Andres E; Gil-Vernet S; Casais LA
    Am J Gastroenterol; 2001 Apr; 96(4):1170-7. PubMed ID: 11316166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute allograft rejection following interferon therapy for hepatitis C in recipients who have returned to dialysis after kidney transplant failure: case study.
    Fabrizi F; D'Ambrosio R; Pallotti F; Berardinelli L; Messa P; Martin P; Aghemo A
    Int J Artif Organs; 2014 Nov; 37(11):803-8. PubMed ID: 25362901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained virological and histological response with pretransplant interferon therapy in renal transplant patients with chronic viral hepatitis C.
    Huraib S; Iqbal A; Tanimu D; Abdullah A
    Am J Nephrol; 2001; 21(6):435-40. PubMed ID: 11799259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of kidney transplant in chronic hepatitis C virus patients: effect of pretransplantation interferon-alpha2b monotherapy.
    González-Roncero F; Gentil MA; Valdivia MA; Algarra G; Pereira P; Toro J; Sayago M; Mateos J
    Transplant Proc; 2003 Aug; 35(5):1745-7. PubMed ID: 12962779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response.
    Espinosa M; Rodriguez M; Martin-Malo A; Alvarez de Lara MA; Gonzalez R; Lopez-Rubio F; de la Mata M; Aljama P
    Clin Nephrol; 2001 Mar; 55(3):220-6. PubMed ID: 11316242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC; Bacon BR; Goldin RD
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy.
    Izopet J; Rostaing L; Moussion F; Alric L; Dubois M; That HT; Payen JL; Duffaut M; Durand D; Suc JM; Puel J
    J Infect Dis; 1997 Dec; 176(6):1614-7. PubMed ID: 9395376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of hepatitis C viremia in renal allograft recipients.
    Mahmoud IM; Sobh MA; Amer GM; El-Chenawy FA; Gazareen SH; El-Sherif A; El-Sawy E; Ghoneim MA
    Am J Nephrol; 1999; 19(5):576-85. PubMed ID: 10575187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation.
    Yedibela S; Schuppan D; Müller V; Schellerer V; Tannapfel A; Hohenberger W; Meyer T
    Liver Int; 2005 Aug; 25(4):717-22. PubMed ID: 15998420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin.
    Gopal DV; Rabkin JM; Berk BS; Corless CL; Chou S; Olyaei A; Orloff SL; Rosen HR
    Liver Transpl; 2001 Mar; 7(3):181-90. PubMed ID: 11244158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
    Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-interferon therapy for chronic hepatitis C may induce acute allograft rejection in kidney transplant patients with failed allografts.
    Wéclawiack H; Kamar N; Mehrenberger M; Guilbeau-Frugier C; Modesto A; Izopet J; Ribes D; Sallusto F; Rostaing L
    Nephrol Dial Transplant; 2008 Mar; 23(3):1043-7. PubMed ID: 17913730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinuria among renal transplant patients and its relation to hepatitis C virus and graft outcome: a single center experience.
    Sabry A
    Exp Clin Transplant; 2010 Jun; 8(2):91-7. PubMed ID: 20565364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
    Payen JL; Izopet J; Galindo-Migeot V; Lauwers-Cances V; Zarski JP; Seigneurin JM; Dussaix E; Voigt JJ; Selves J; Barange K; Puel J; Pascal JP
    Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained response with negative serum HCV-mRNA and disappearance of antibodies after interferon-alpha therapy in a kidney transplant recipient with chronic active viral hepatitis C.
    Luciani G; Bossola M; Muscaritoli M; Panocchia N; Ferrante A; Nanni G; Piccioni E; Tazza L; Grillo RL; Rossi Fanelli F; Castagneto M
    J Nephrol; 2003; 16(3):417-20. PubMed ID: 12832744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HCV RNA clearance after treatment with interferon-alpha in chronic hemodialysis patients with or without coinfection by HGV/HGBV-C].
    Rostaing L; Izopet J; Moussion F; Alric L; Verdier D; That HT; Duffaut M; Durand D; Puel J; Suc JM
    Nephrologie; 1997; 18(7):281-6. PubMed ID: 9496568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.
    Samuel D; Bizollon T; Feray C; Roche B; Ahmed SN; Lemonnier C; Cohard M; Reynes M; Chevallier M; Ducerf C; Baulieux J; Geffner M; Albrecht JK; Bismuth H; Trepo C
    Gastroenterology; 2003 Mar; 124(3):642-50. PubMed ID: 12612903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.